Abstract

Firstly, the idea of using nanotechnology in medicine was developed from a creative imagination which based on that small machine men can be designed and after entering these machines into the human body they are used to perform molecular restorations at the cellular level. Also, in this research we introduce common nanoparticles, fullerenes, nano micelles solid lipid nanoparticles, metal nanoparticles, polymeric nanoparticles, dendrimers, nano shells, quantum dots, nano liposomes. In this research, the features of particles and know structures and applicable in drug delivery are mentioned. The purpose of this research is to introduce the application of nanoparticles for Nano medicine for excellence in nano medicine development.

Keywords: Nanoparticles; Dendrimers; Solid Lipid Nanoparticles; Nano Shells

References

1. Lewenstein., et al. “Nanotechnology in the media: A preliminary analysis. Nanotechnology: Societal Implications II: Individual Perspectives. Dordrecht. Springer (2007): 258-265.
2. Drexler., et al. “Unbounding the future: the nanotechnology revolution” (1991).
3. Freitas RA. “Nanomedicine, volume I: basic capabilities”. Volume 1: Landes Bioscience Georgetown, TX (1999).
4. Freitas Jr RA. “What is nanomedicine?” Nanomedicine: Nanotechnology, Biology and Medicine 1.1 (2005): 2-9.
5. Feynman RP. “There's plenty of room at the bottom”. California Institute of Technology, Engineering and Science magazine (1960).
6. Krätschmer W., et al. “Solid C60: a new form of carbon”. Nature 347.6291 (1990): 354.
7. Alekseyev N and G Dyuzhev. “Fullerene formation in an arc discharge”. Carbon 41.7 (2003): 1343-1348.
8. Howard JB., et al. “Fullerenes C60 and C70 in flames”. Nature 352.6331 (1991): 139.
9. Goel A and JB Howard. “Reaction rate coefficient of fullerene (C60) consumption by soot”. Carbon 41.10 (2003): 1949-1954.
10. Boorum MM., et al. “Groundwork for a rational synthesis of C60: cyclodehydrogenation of a C60H30 polyarene”. Science 294.5543 (2001): 828-831.
11. Scott LT., et al. “A rational chemical synthesis of C60”. Science 295.5559 (2001): 1500-1503.
12. Hirsch A. “The chemistry of the fullerenes: an overview”. Angewandte Chemie International Edition in English 32.8 (1993): 1138-1141.
13. Seetharamappa J., et al. “Carbon nanotubes”. Electrochemical society interface (2006).
14. Cox B and J Hill. “A polyhedral model for carbon nanotubes” (2007).
15. Kagan V., et al. “Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron”. Toxicology Letters 165.1 (2006): 88-100.
16. Periyakaruppan A., et al.” Uranium induces oxidative stress in lung epithelial cells”. Archives of toxicology 81.6 (2007): 389-395.
17. Wu G., et al. “Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells”. Journal of the American Chemical Society 130.26 (2008): 8175-8177.
18. Papahadjopoulos D. “Liposomes and their uses in biology and medicine”. Annals of the New York Academy of Sciences (1978): 308-324.
19. Bangham AD. “Surrogate cells or Trojan horses. The discovery of liposomes”. BioEssays 17.12 (1995): 1081-1088.
20. Stoyanov ES. “New type of nanoparticles, nanomicelles formed in water-saturated organic solutions of HFeCl₄ and HClO₄: Composition, structure and properties”. Journal of the Chemical Society, Faraday Transactions 94.18 (1998): 2803-2812.
21. Muller RH. “Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery”. The European Journal of Pharmaceutics and Biopharmaceutics 41 (1995): 62-69.
22. Siekmann B and K Westesen. “Submicron-sized parenteral carrier systems based on solid lipids”. Pharmaceutical and Pharmacological Letters 1.3 (1992): 123-126.
23. Muller R. “Arzneistofftrager aus festen lipidteilchen (Feste Lipidnanospharen (SLN))”. European Patent Office B1 (1996).
24. Faraji AH and P Wipf. “Nanoparticles in cellular drug delivery”. Bioorganic and Medicinal Chemistry 17.8 (2009): 2950-2962.
25. Ahmad J., et al. “Solid matrix based lipidic nanoparticles in oral cancer chemotherapy: applications and pharmacokinetics”. Current Drug Metabolism 16.8 (2015): 633-644.
26. Choy JH., et al. “Cellular uptake behavior of [γ-32P] labeled ATP-LDH nanohybridsElectronic supplementary information (ESI) available: histogram for Mg solubility of Mg₂Al-LDH as a function of pH; FITC-LDH exchange rate according to NaCl concentration (FITC= fluorescein 5-isothiocyanate); cytotoxicity test of Mg₂Al-NO₃−-LDH”. Journal of Materials Chemistry 11.6 (2001): 1671-1674.
27. Xu ZP., et al. “Dispersion and size control of layered double hydroxide nanoparticles in aqueous solutions”. The Journal of Physical Chemistry B 110.34 (2006): 16923-16929.
28. Mulvaney P. “Nanoscience vs Nanotechnology Defining the Field”. ACS Publications (2015).
29. Brust, M., et al. “Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system”. Journal of the Chemical Society, Chemical Communications 7 (1994): 801-802.
30. Choi O and Z Hu. “Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria”. Environmental science & technology 42.12 (2008): 4583-4588.
31. Chen X and HJ Schluesener.” Nanosilver: a nanoproduct in medical application”. Toxicology letters, 176.1 (2008): 1-12.
32. Prabha S and V Labhasetwar. “Critical determinants in PLGA/PLA nanoparticle-mediated gene expression”. Pharmaceutical Research 21.2 (2004): 354-364.
33. Alyautdin RN., et al. “Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated poly butyl cyanoacrylate nanoparticles”. Pharmaceutical Research 14.3 (1997): 325-328.
34. Kreuter J., et al. “Direct evidence that polysorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles”. Pharmaceutical Research 20.3 (2003): 409-416.
35. Danhier F., et al. “PLGA-based nanoparticles: an overview of biomedical applications”. Journal of Controlled Release 161.2 (2012): 505-522.
36. Murakami H., et al. “Preparation of poly (DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method”. International Journal of Pharmaceutics 187.2 (1999): 143-152.
37. Grinstaff MW. “Bio dendrimers: new polymeric biomaterials for tissue engineering”. Chemistry-A European Journal 8.13 (2002): 2838-2846.
38. Lee CC., et al. “Designing dendrimers for biological applications”. Nature Biotechnology 23.12 (2005): 1517.
39. West JL and NJ Halas. “Applications of nanotechnology to biotechnology: Commentary”. Current Opinion in Biotechnology 11.2 (2000): 215-217.
40. Sershen S., et al. “Temperature‐sensitive polymer-nano shell composites for photothermally modulated drug delivery”. Journal of Biomedical Materials Research 51.3 (2000): 293-298.